(Q43602420)

25 November 2017

Therapeutic effects of FTY720, a new immunosuppressive agent, in a murine model of acute viral myocarditis (English)

1 reference

25 November 2017

1 reference

Miyamoto T

1

1 reference

25 November 2017

Matsumori A

2

1 reference

25 November 2017

Hwang MW

3

1 reference

25 November 2017

Nishio R

4

1 reference

25 November 2017

Ito H

5

1 reference

25 November 2017

Sasayama S

6

1 reference

25 November 2017

language of work or name

English

0 references

publication date

1 May 2001

1 reference

Journal of the American College of Cardiology

25 November 2017

1 reference

25 November 2017

37

1 reference

25 November 2017

6

1 reference

25 November 2017

1713-1718

1 reference

From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Molecular and immune mechanisms in the pathogenesis of cardiomyopathy--role of viruses, cytokines, and nitric oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Effects of prednisolone on acute viral myocarditis in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Coxsackievirus B3 infection leads to cell death of cardiac myocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Therapy with cyclosporine in experimental murine myocarditis with encephalomyocarditis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

The effects of cyclosporine on acute murine Coxsackie B3 myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Treatment of experimental murine coxsackie B3 myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

A clinical trial of immunosuppressive therapy for myocarditis. The Myocarditis Treatment Trial Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Simple compounds, 2-alkyl-2-amino-1,3-propanediols have potent immunosuppressive activity

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Design, synthesis, and structure-activity relationships of 2-substituted-2-amino-1,3-propanediols: Discovery of a novel immunosuppressant, FTY720

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Immunosuppressants: cellular and molecular mechanisms of action

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

FTY720, a novel immunosuppressant, induces sequestration of circulating mature lymphocytes by acceleration of lymphocyte homing in rats, III. Increase in frequency of CD62L-positive T cells in Peyer's patches by FTY720-induced lymphocyte homing

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Analysis of the mode of action of a novel immunosuppressant FTY720 in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

A novel immunosuppressant, FTY720, with a unique mechanism of action, induces long-term graft acceptance in rat and dog allotransplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

FTY720: mechanisms of action and its effect on organ transplantation (review).

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

FTY720, a new immunosuppressant, promotes long-term graft survival and inhibits the progression of graft coronary artery disease in a murine model of cardiac transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

An experimental model for congestive heart failure after encephalomyocarditis virus myocarditis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Therapeutic effect of anti-tumor necrosis factor-alpha antibody on the murine model of viral myocarditis induced by encephalomyocarditis virus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Treatment of experimental viral myocarditis with interleukin-10

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Pimobendan inhibits the production of proinflammatory cytokines and gene expression of inducible nitric oxide synthase in a murine model of viral myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Sample pretreatment with nitrate reductase and glucose-6-phosphate dehydrogenase quantitatively reduces nitrate while avoiding interference by NADP+ when the Griess reaction is used to assay for nitrite

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Protective role of interleukin-12 in viral myocarditis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Pathogenesis and preventive and therapeutic trials in an animal model of dilated cardiomyopathy induced by a virus

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Quantitating immunosuppression. Estimating the 50% inhibitory concentration for in vivo cyclosporine in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

FTY720 prevents development of experimental autoimmune myocarditis through reduction of circulating lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

An immunosuppressant compound, FK-506, prevents the progression of autoimmune myocarditis in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

FK506 therapy of experimental autoimmune myocarditis after onset of the disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Immunosuppressive and immunomodulatory treatment for myocarditis.

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Functional diversity of helper T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Therapeutic actions of cyclosporine and anti-tumor necrosis factor alpha in collagen-induced arthritis and the effect of combination therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Persistent expression of cytokine in the chronic stage of viral myocarditis in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Differential modulation of cytokine production by drugs: implications for therapy in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

Inotropic agents differentially inhibit the induction of nitric oxide synthase by endotoxin in cultured macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

The use of cytokine inhibitors. A new therapeutic insight into heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2801%2901204-9

7 January 2021

10.1016/S0735-1097(01)01204-9

Identifiers

DOI

1 reference

25 November 2017

1 reference